Please use this identifier to cite or link to this item:
Title: Drug discovery to reverse clarithromycin resistance in multidrug-resistant mycobacterium abscessus
Authors: Dam, Linh Chi
Keywords: DRNTU::Science::Biological sciences
Issue Date: 2019
Abstract: Mycobacterium abscessus is an emerging life-threatening non-tuberculous mycobacterium with extensive drug-resistance mechanisms. M. abscessus infections have been causing substantial economic burden, due to the lengthy treatment lasting up to 24 months with multi-drug regimens. Despite this extensive treatment, M. abscessus infections still remain incurable. Thus, instead of developing new antibiotics, our objective is to identify an adjuvant that can be employed together with clarithromycin, its first-line treatment, to reverse clarithromycin resistance in M. abscessus. Clarithromycin resistance in M. abscessus is conferred by inducible erythromycin ribosome methylase (Erm) 41 enzyme. We first developed an optimized and novel induction protocol to induce clarithromycin resistance in M. abscessus, suitable for low cost and high-throughput drug screening. Two-stage screening was then used to screen nearly 2,200 compounds against resistant M. abscessus at single concentration (20 μM). Hits were validated as potential clarithromycin adjuvant in dose-response and checkerboard assay. Three promising adjuvant candidates were identified with good clarithromycin potentiation activity, with two have been validated to exert synergistic effect with clarithromycin while demonstrating negligible inhibition when used alone. Our approach of antibiotic adjuvant employing novel clarithromycin induction drug screening assay pave promising path to M. abscessus drug discovery and development.
Schools: School of Biological Sciences 
Research Centres: Singapore-MIT Alliance Programme 
Rights: Nanyang Technological University
Fulltext Permission: restricted
Fulltext Availability: With Fulltext
Appears in Collections:SBS Student Reports (FYP/IA/PA/PI)

Files in This Item:
File Description SizeFormat 
FYP thesis-IP.pdf
  Restricted Access
892.85 kBAdobe PDFView/Open

Page view(s)

Updated on Sep 23, 2023


Updated on Sep 23, 2023

Google ScholarTM


Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.